AbbVie Inc (ABBV)
200.51
-0.69
(-0.34%)
USD |
NYSE |
Nov 07, 16:00
201.00
+0.49
(+0.24%)
Pre-Market: 08:35
AbbVie Revenue (TTM): 55.53B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.53B |
| June 30, 2024 | 55.00B |
| March 31, 2024 | 54.40B |
| December 31, 2023 | 54.32B |
| September 30, 2023 | 55.14B |
| June 30, 2023 | 56.02B |
| March 31, 2023 | 56.74B |
| December 31, 2022 | 58.05B |
| September 30, 2022 | 57.82B |
| June 30, 2022 | 57.35B |
| March 31, 2022 | 56.72B |
| December 31, 2021 | 56.20B |
| September 30, 2021 | 55.17B |
| June 30, 2021 | 53.73B |
| March 31, 2021 | 50.20B |
| December 31, 2020 | 45.80B |
| September 30, 2020 | 40.65B |
| June 30, 2020 | 36.23B |
| March 31, 2020 | 34.06B |
| December 31, 2019 | 33.27B |
| September 30, 2019 | 32.87B |
| June 30, 2019 | 32.62B |
| March 31, 2019 | 32.65B |
| December 31, 2018 | 32.75B |
| September 30, 2018 | 32.19B |
| Date | Value |
|---|---|
| June 30, 2018 | 30.95B |
| March 31, 2018 | 29.61B |
| December 31, 2017 | 28.22B |
| September 30, 2017 | 27.27B |
| June 30, 2017 | 26.71B |
| March 31, 2017 | 26.22B |
| December 31, 2016 | 25.64B |
| September 30, 2016 | 25.24B |
| June 30, 2016 | 24.75B |
| March 31, 2016 | 23.78B |
| December 31, 2015 | 22.86B |
| September 30, 2015 | 21.91B |
| June 30, 2015 | 20.99B |
| March 31, 2015 | 20.44B |
| December 31, 2014 | 19.96B |
| September 30, 2014 | 19.62B |
| June 30, 2014 | 19.26B |
| March 31, 2014 | 19.02B |
| December 31, 2013 | 18.79B |
| September 30, 2013 | 18.88B |
| June 30, 2013 | 18.74B |
| March 31, 2013 | 18.54B |
| December 31, 2012 | 18.38B |
| September 30, 2012 | 18.04B |
| June 30, 2012 | 17.94B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
33.27B
Minimum
Dec 2019
58.05B
Maximum
Dec 2022
51.12B
Average
55.07B
Median
Revenue (TTM) Benchmarks
| Amgen Inc | 32.53B |
| Johnson & Johnson | 87.70B |
| Eli Lilly and Co | 40.86B |
| Merck & Co Inc | 63.17B |
| Pfizer Inc | 59.37B |